Back
Harrow Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
54
HROW
Harrow
Last Price:
42.86
Seasonality Move:
5.55%
Sell
38
NBY
NovaBay Pharmaceuticals
Last Price:
0.73
Seasonality Move:
-7.72%
Buy
54
Harrow (HROW)
is a Buy
Is Harrow a Buy, Sell or Hold?
- The current Harrow [HROW] share price is $42.86. The Score for HROW is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- HROW is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.73. The Score for NBY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HROW Stock Price Chart
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.73
The current trend is relatively stagnant and NBY is experiencing slight buying pressure.
HROW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 38.25 | Sell |
| Chaikin Money Flow: | 141858 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.22 - 54.28) | Sell |
| Bollinger Bands (100): | (27.28 - 49.68) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 55.4 | Buy |
| Chaikin Money Flow: | 14807 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.59 - 0.73) | Buy |
| Bollinger Bands (100): | (0.28 - 1.6) | Sell |
HROW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.13 | Sell |
| 20-day SMA: | 49.83 | Sell |
| 50-day SMA: | 47.57 | Sell |
| 200-day SMA: | 25.76 | Buy |
| 8-day EMA: | 48.52 | Sell |
| 20-day EMA: | 48.9 | Sell |
| 50-day EMA: | 46.29 | Sell |
| 200-day EMA: | 31.19 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.72 | Buy |
| 20-day SMA: | 0.68 | Buy |
| 50-day SMA: | 0.63 | Buy |
| 200-day SMA: | 2.47 | Sell |
| 8-day EMA: | 0.72 | Buy |
| 20-day EMA: | 0.69 | Buy |
| 50-day EMA: | 0.74 | Sell |
| 200-day EMA: | 5.87 | Sell |
Harrow Earnings Growth & HROW Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and an increase next year of $1.01 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Harrow Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||